Cancer Reports (Oct 2023)

The uterine adenosarcoma with postoperative residual in a woman treated by total abdominal hysterectomy/bilateral salpingo‐oophorectomy: A case report and review of literature

  • Pedram Fadavi,
  • Maryam Garousi,
  • Sepideh Soltani,
  • Fatemeh Montazer,
  • Maryam Abolhasani,
  • Salar Asgari,
  • Elahe Mirzaee

DOI
https://doi.org/10.1002/cnr2.1891
Journal volume & issue
Vol. 6, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract Background In patients with uterine adenosarcoma, a total abdominal hysterectomy (TAH) with bilateral salpingo‐oophorectomy (BSO) is typically recommended as an initial treatment. There is no consensus on adjuvant therapies. Case We report the case of a patient with uterine adenosarcoma with postoperative residual disease. We performed four courses of adjuvant chemotherapy, including Ifosfamide, Mesna, and Adriamycin, and whole pelvic radiation with a dose of 50.4 Gy/28 Fr. Conclusion A combination of chemotherapy and radiotherapy may be a promising treatment option for uterine adenosarcoma with postoperative residual disease.

Keywords